Live from CROI 2023 – Kim Smith, ViiV Healthcare: CabLA for African Girls and Women
Ben and Yvette have a rather vigorous but hugely engaging conversation with friend of the Pod, Dr. Kimberly Smith, the Head of R&D for ViiV Healthcare, on what’s needed to ensure that the potential of long acting injectable antiretrovirals – for both HIV prevention & treatment – are realized for girls and women in sub-Saharan Africa. With its costs and manufacturing complexity – will CabLA be a truly a game changer or an afterthought?
And Kim promised to check whether the regulatory submission formulation of long-acting cabotegravir and rilpivirine for treatment has been filed in South Africa already: It was, in September 2021.
#CROI_2023 #HIV #prevention #treatment #longacting #CabLA #vaccine #pandemics #access #affordability #techtransfer #voluntarylicense